Ad
related to: fda approved soravtansine gynx treatment- Acromegaly Hidden Impact
Extended info on the hidden
impact of Acromegaly.
- Let's Rethink Acromegaly
Expanded library of acromegaly
information.
- Keep Up To Date
Stay informed and receive
updates about Acromegaly.
- Take Charge of Your Care
Empowering Acromegaly patients
with information and resources.
- Acromegaly Hidden Impact
Search results
Results from the WOW.Com Content Network
Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.
The mirvetuximab, which has been submitted for FDA approval, is being developed as a monotherapy or a standalone treatment for ovarian cancer. [7] [8] Other products currently in clinical-stage development include: [9] IMGN853, (mirvetuximab soravtansine) targeting FRα, and using DM4. [10] IMGN529, targeting CD37 for Non-Hodgkin lymphoma (NHL ...
Sulopenem/probenecid, sold under the brand name Orlynvah, is a fixed-dose combination medication used for the treatment of urinary tract infections. [1] It contains sulopenem, a penem antibacterial, as the prodrug sulopenem etzadroxil; and probenecid, a renal tubular transport inhibitor.
Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of aging,” Barzilai says. While not approved as anti-aging treatments ...
In August the Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication to treat postpartum depression. The approval is a big step for women with the condition, which ...
In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals followed intense lobbying by advocacy groups.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
The KarXT approval comes after decades of no significant treatment advancements for schizophrenia patients. About 3.7 million, or 1.8%, of adults in the U.S. have a lifetime history of ...
Ad
related to: fda approved soravtansine gynx treatment